Voyager Therapeutics (VYGR) Net Cash Flow Growth (5y) (2019 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Net Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -179.20% |
| Mar 31, 2026 | -29.53% |
| Dec 31, 2025 | 19.16% |
| Sep 30, 2025 | 4.66% |
| Jun 30, 2025 | -8.07% |
| Mar 31, 2025 | -46.90% |
| Dec 31, 2024 | -69.76% |
| Sep 30, 2024 | 67.57% |
| Jun 30, 2024 | -14.94% |
| Mar 31, 2024 | 2.62% |
| Dec 31, 2023 | -5.62% |
| Sep 30, 2023 | -59.26% |
| Jun 30, 2023 | 21.58% |
| Mar 31, 2023 | 9.25% |
| Dec 31, 2022 | 16.28% |
| Sep 30, 2022 | 24.77% |
| Jun 30, 2022 | -34.31% |
| Mar 31, 2022 | 15.71% |
| Dec 31, 2021 | 17.35% |
| Sep 30, 2021 | -12.56% |